Skip to main navigation
Skip to search
Skip to main content
Prince Sattam bin Abdulaziz University Home
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Search by expertise, name or affiliation
CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment
Shunshun Bao
, Mohammad Darvishi
, Ali H Amin
, Maysoon T. Al-Haideri
, Indrajit Patra
, Khadisha Kashikova
, Irfan Ahmad
,
Fahad Alsaikhan
, Zahraa Haleem Al-qaim
, Moaed E. Al-Gazally
, Bahman Abedi Kiasari
, Bahareh Tavakoli-Far
, Akmal A. Sidikov
, Yasser Fakri Mustafa
, Reza Akhavan-Sigari
Clinical Pharmacy
Xuzhou Medical University
AJA University of Medicinal Sciences
Umm Al-Qura University
Mansoura University
Cihan University-Erbil
National Institute of Technology, Durgapur
Kazakh National Medical University
King Khalid University
Al-Mustaqbal University College
University of Al-Ameed
University of Tehran
Alborz University of Medical Sciences
Fergana Medical Institute of Public Health
University of Mosul
University of Tübingen
Collegium Humanum Warsaw Management University
Research output
:
Contribution to journal
›
Review article
›
peer-review
29
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cancer Therapy
100%
Tumor Progression
25%
Gene Expression
12%
Antineoplastic Activity
12%
Cell Proliferation
12%
Angiogenesis
12%
Metastatic Carcinoma
12%
Cell Signaling Pathway
12%
Carcinogenesis
12%
G Protein Coupled Receptor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Tumor Growth
25%
Neoplasm
12%
Carcinogenesis
12%
G Protein Coupled Receptor
12%
Tissue Repair
12%
Immunology and Microbiology
Stromal Cell-Derived Factor 1
62%
Cell Proliferation
12%
Angiogenesis
12%
Gene Expression
12%
Physiological Process
12%
Antineoplastic Activity
12%